Head office: +98 21 8854 0521 Saturday to Wednesday, 8:00–17:00 info@meshcutpharmed.com Contact usPartnership
Meshkat Pharmed DistributionMeshkat Pharmed DistributionNationwide distribution of medicines and health products

UK regulator bans stem-cell treatment ads as “misleading”

The UK advertising watchdog has banned ads from four companies promoting stem-cell treatment for autism in children, ruling them misleading.

ArticleNovember 11, 2026
UK regulator bans stem-cell treatment ads as “misleading”

The UK advertising watchdog has banned ads from four companies promoting stem-cell treatment for autism in children, ruling them misleading.

The Advertising Standards Authority (ASA) issued the rulings on specific ads by three Turkish companies (Linden Stem Cell, Rumi Pulse Medical Tourism Agency and You Clinic Turkey) and one Serbian company (Swiss Medica XXI Century).

The rulings cover five ads that appeared in 2026 on Google and Meta platforms (including Facebook and Instagram) in the UK.

An ASA spokesperson said the regulator received a complaint from a member of the public about one of the ads, which prompted it to examine whether other clinics were making similar claims.

“We found that such claims were being made. Given the vulnerability of the audience and the potential for serious harm and detriment from misleading claims about treating autism, we launched a number of proactive investigations,” the spokesperson said.

The spokesperson added that the banned ads are the latest examples of “ads making claims to cure or treat autism without sufficient evidence.”

Other examples previously investigated and banned by the ASA include autism-related ads for food supplements and other products.

Source: BMJ

This article is for educational and informational purposes only and is not a substitute for advice, diagnosis or treatment by a physician or pharmacist.

Original Persian text: meshcutpharmed.com